The global Cancer Biopsy Market is on a transformative growth trajectory, projected to rise from USD 28.12 billion in 2023 to an impressive USD 85.03 billion by 2032, advancing at a compound annual growth rate (CAGR) of 13.0% from 2024 to 2032. This surge reflects significant progress in early cancer detection, rising cancer prevalence, and major technological innovations in biopsy procedures....